Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.
Mahad D, Callahan MK, Williams KA, Ubogu EE, Kivisäkk P, Tucky B, Kidd G, Kingsbury GA, Chang A, Fox RJ, Mack M, Sniderman MB, Ravid R, Staugaitis SM, Stins MF, Ransohoff RM.
Mahad D, et al. Among authors: ransohoff rm.
Brain. 2006 Jan;129(Pt 1):212-23. doi: 10.1093/brain/awh655. Epub 2005 Oct 17.
Brain. 2006.
PMID: 16230319